Viewing Study NCT02264067


Ignite Creation Date: 2025-12-25 @ 12:31 AM
Ignite Modification Date: 2026-02-06 @ 5:40 AM
Study NCT ID: NCT02264067
Status: COMPLETED
Last Update Posted: 2014-10-15
First Post: 2014-10-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers
Sponsor: Boehringer Ingelheim
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 506.111
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators